WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a recognized leader in RNAi-based therapeutic discovery and development, today announced that the Company's President and Chief Executive Officer, Noah D. Beerman, will present a corporate overview at the Jefferies 2010 Global Life Sciences Conference on Thursday, June 10, 2010 at 3:00 p.m. ET in New York City. Mr. Beerman’s presentation will also include, for the first time, a description of the company’s focused therapeutic strategy for its next generation RNAi technology.
